SweetBio key facts
as of Oct 2026- Developer of wound care products designed to aid the healing of non-healing wounds.
- SweetBio is valued at approximately $15.0M as of Oct 2026, set at its later-stage round, Jan 2021; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $8.3M across 4 recorded rounds; the latest was Seed Round ($590K) in Oct 2020.
- Notable investors include Springboard Enterprises, Launch Tennessee, InvestTN, 1945 Capital, Apple — 12 tracked in total.
- SweetBio has filed 8 Form Ds with the SEC since 2015, most recently Apr 2024 ( sold).
- Status: Privately Held (backing).
Valued at $15.0M at its later-stage round, Jan 2021. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch SweetBio: the Monday email on marks, rounds and moves
SweetBio funding rounds
4 roundsWho backs SweetBio
12+SweetBio valuation
SweetBio was valued at $15 million at its later-stage round in Jan 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has SweetBio raised?
SweetBio has raised $8.3 million across 4 recorded rounds since 2018. The largest was an $803,600 seed round in Aug 2019; the most recent was a $590,000 seed round in Oct 2020.
SweetBio has filed 8 Form Ds with the SEC since 2015, most recently in Apr 2024 (null sold).
SweetBio investors
12 investors are on record for SweetBio, including Springboard Enterprises, Launch Tennessee, InvestTN and 1945 Capital. The seed round in Oct 2020 drew 13 investors.
About SweetBio
Developer of wound care products designed to aid the healing of non-healing wounds. The company offers honey-based dressings that are simple to apply and reduce residue, enabling patients and caregivers to manage wound care with less complexity.
- Industry
- Medical Supplies
- Sector
- Healthcare
- HQ
- Memphis, TN, United States
- Founded
- 2015
- Employees
- 10
- Website
- sweetbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.